Skip to main content

Table 1 Characteristics of the patients that were included in the study

From: Factors that affect the assessment of the quality of life of rheumatoid arthritis patients depending on the prevalence of frailty syndrome

Parameters

Whole group

Robust (69)

Frail (38)

p

Place of living (urban/rural area)

29/77

16/53

13/24

0.79

Education (primary/vocational/

secondary/higher)

15/34/37/20

9/20/28/12

6/14/9/8

0.95

Marital Status (unmarried/married/

living with partner/widow;widower or divorced)

2/69/29/6

1/45/19/4

1/24/10/2

1

Professional status (working/ not working/retired/pensioner on benefits)

10/10/17/69

4/4/13/48

6/6/4/21

0.52

Type of work (physical/mental)

59/47

37/32

22/15

0.99

Drinking coffee (n): yes/no

89

59

30

0.99

Drinking alcohol (n): yes/no

20

13

7

1

Drugs (n): Methotrexat / NSAiD/ glucocorticosteroids/ etanercept/ Adalimumab

106/20/24/18/12

69/17/20/12/7

37/15/11/6/5

0.74

 

median

1st quartile

3rd quartile

median

1st quartile

3rd quartile

median

1st quartile

3rd quartile

p

Age (years)

65

62

68

65

63

68

65

62

68

0.75a

Duration of disease (months)

142

72

240

180

90

240

120

60

240

0.20

Number of painful joints (n)

6

4

8

6

4

10

6

4

8

0.49

Number of swollen joints (n)

4

2

6

4

2

7

4

2

4

0.24

Duration of morning stiffness (minutes)

60

30

60

60

30

60

45

20

60

0.22

BMI (kg/m2)

26.89

24.09

29.35

26.93

23.8

29.35

26.84

24.8

29.24

0.46

VAS

55

45

65

55

45

65

56

42

65

0.68a

Red blood cell

4.34

4.12

4.68

4.32

4.12

4.6

4.41

4.14

4.8

0.09

ESR

17.5

13

28

20

13

32

16

13

20

0.05

CRP

0.73

0.42

1.48

0.74

0.49

1.52

0.7

0.42

1.25

0.38

Creatine

0.76

0.7

0.85

0.78

0.7

0.85

0.73

0.7

0.84

0.11

ALAT

22

17

28

21

16

24

23

19

31

0.01a

ASPAT

22

18

25

22

18

24

22

18

25

0.44a

DAS-28

4.71

4.24

5.38

4.86

4.16

5.64

4.6

4.26

4.95

0.02a

DAS-28-CRP

3.92

3.41

4.58

3.99

3.41

4.69

3.84

3.41

4.20

0.049a

Acceptance of illness

27

21

33

26

20

32.5

30

23

34

0.28a

Smoking (nonsmoker/smoker)

Number of days

15

8

7

0.90

10

5

15

10

6

12.5

10

5

18

0.97a

Smoking in the past

Number of days

Number smoking years

35

25

10

0.92

10

5

20

10

5

20

10

7

20

0.51a

20

15

30

20

15

30

22

15

30

0.39a

  1. Abbreviations: AlAT alanine transaminase, AspAT aspartate transaminase, BMI body mass index, CRP C-reactive protein, DAS-28 28-Joint Disease Activity Score, ESR erythrocyte sedimentation rate, IQR interquartile range, P statistical significance of differences, VAS Visual Analog Scale
  2. aT-Student test